Fragrance makers are trying notes like cherry and tabasco to see whether GLP-1 users want food-themed perfumes.
Recap by typeshit. Full story at Reuters.
A short Facebook share with no context on who used the peptides, where it happened or what followed.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
2:07:50
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
Eric Fry sees upside on Wegovy pill demand, while Zacks expects 2026 revenue and EPS to fall. The FDA call on CagriSema is expected in Q4 2026.
A group of MPs is pressing for faster access to Mounjaro through the NHS, Sky News reports.
Loading…